Jeff Yass’s ENDRA Life Sciences Inc. Warrants NDRAW Stock Holding History

Jeff Yass’s Portfolio NDRAW Stock Details NDRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,319	Closed	-$3K	–	14494
2021 Q4	$3K	Buy	+33,319	New	+$7.64K	﹤0.01%	13006
2020 Q3	–	Sell	-35,297	Closed	-$6K	–	11398
2020 Q2	$6K	Buy	35,297 +24,908	+240%	+$4.24K	﹤0.01%	10003
2020 Q1	$2K	Buy	+10,389	New	+$3.48K	﹤0.01%	10130

Jeff Yass's NDRAW Position: Q1 2022 in Review

Jeff Yass sold out of ENDRA Life Sciences Inc. Warrants (NDRAW) in Q1 2022, closing a stake of 33,319 shares — an estimated $3K sold.

Jeff Yass first reported a position in NDRAW in Q1 2020 and held it in 3 quarters. The position peaked at $6K in Q2 2020. 1 fund tracked by Wall St. Rank holds NDRAW as of Q1 2022.

Jeff Yass reported no remaining ENDRA Life Sciences Inc. Warrants position as of Q1 2022 after selling out during the quarter.
Jeff Yass sold 33,319 ENDRA Life Sciences Inc. Warrants shares in Q1 2022, an estimated $3K.
Jeff Yass first reported a position in ENDRA Life Sciences Inc. Warrants in Q1 2020 and held it in 3 quarters.
Jeff Yass's ENDRA Life Sciences Inc. Warrants position peaked at $6K in Q2 2020.
1 fund tracked by Wall St. Rank held ENDRA Life Sciences Inc. Warrants as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.